» Articles » PMID: 31571725

Protective Efficacy of a Vaccine Using a -based Delivery System Expressing Omp3b, BCSP31, and SOD Proteins Against Brucellosis in Korean Black Goats

Overview
Journal Can J Vet Res
Date 2019 Oct 2
PMID 31571725
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to assess the protective efficacy of a novel vaccine formulation in goats. Twenty black goats were separated into 2 groups. Group A was injected with 3.0 × 10 CFU (colony-forming units)/mL of a -based delivery system harboring only vector (pMMP65). Group B was immunized with 3.0 × 10 CFU/mL of the vaccine, a mixture of 3 vaccine strains (using a -based delivery system) expressing each recombinant Omp3b, BCSP31, and SOD protein. No delivery strain was isolated from all tested lymph nodes and parenchymal organs. Serum immunoglobulin (Ig) G titers and interferon gamma concentrations were significantly higher in group B than those in group A. After intraconjunctival challenge with virulent strain 544, 40% of the vaccinated animals in group B were protected against infection. The infection index and colonization of in tested tissues was significantly lower in group B than group A. We conclude that this vaccine induces significant antigen-specific immune responses and provides effective protection against infection in goats. Further studies are needed to enhance the protection rate of this vaccine and to discover its practical application in small ruminants.

Citing Articles

Recombinant Live-Attenuated Vaccine for Veterinary Use.

Chagas D, Santos F, de Oliveira N, Bohn T, Dellagostin O Vaccines (Basel). 2025; 12(12.

PMID: 39771981 PMC: 11680399. DOI: 10.3390/vaccines12121319.


Brucellosis detection and the role of spp. cell wall proteins.

Bulashev A, Eskendirova S Vet World. 2023; 16(7):1390-1399.

PMID: 37621538 PMC: 10446727. DOI: 10.14202/vetworld.2023.1390-1399.

References
1.
Oliveira S, Splitter G . CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur J Immunol. 1995; 25(9):2551-7. DOI: 10.1002/eji.1830250922. View

2.
Hur J, Lee J . Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model. J Vet Med Sci. 2011; 73(10):1265-73. DOI: 10.1292/jvms.11-0087. View

3.
Olsen S . Recent developments in livestock and wildlife brucellosis vaccination. Rev Sci Tech. 2013; 32(1):207-17. DOI: 10.20506/rst.32.1.2201. View

4.
Bowden R, Cloeckaert A, Zygmunt M, Bernard S, Dubray G . Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry. Infect Immun. 1995; 63(10):3945-52. PMC: 173554. DOI: 10.1128/iai.63.10.3945-3952.1995. View

5.
Leal-Klevezas D, Lopez-Merino A, Martinez-Soriano J . Use of polymerase chain reaction to detect Brucella abortus biovar 1 in infected goats. Vet Microbiol. 2000; 75(1):91-7. DOI: 10.1016/s0378-1135(00)00200-5. View